Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 167   

Articles published

GSK 1,467.00 -25.50 (-1.71%)
price chart
Company News: GlaxoSmithKline plc (ADR) (NYSE:GSK)
GlaxoSmithKline plc (ADR) (NYSE:GSK) announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US.
GlaxoSmithKline plc Receives $50.67 Consensus Price Target from Brokerages ...  sleekmoney
GlaxoSmithKline plc (ADR) Witness Large Outflow of Money  Stafford Daily
GlaxoSmithKline plc (ADR) Analyst Rating Update
As many as 8 brokerage firms have rated GlaxoSmithKline plc (ADR) (NYSE:GSK) at 3.13. Research Analysts at Zacks have ranked the company at 5, suggesting the traders with a rating of Underperform.
Form 6-K GLAXOSMITHKLINE PLC For: Jan 28
GlaxoSmithKline plc (LSE/NYSE: GSK) has today received clearance from the European Commission of its proposed three-part transaction with Novartis which includes the acquisition of Novartis's vaccines business (excluding influenza vaccines), the ...
EU Approves Three-Part Deal Between Novartis, GlaxoSmithKline  Wall Street Journal
News Recap - GlaxoSmithKline (GSK), Royal Dutch Shell (RDS.A), Sony (SNE ...  Techsonian (press release)
Are Glaxosmithkline Plc (ADR) (NYSE:GSK) And Pfizer Inc. (NYSE:PFE ...
Doctors without Borders recently blamed GlaxoSmithKline plc (ADR) (NYSE:GSK) and Pfizer Inc. (NYSE:PFE) for overcharging vaccine prices in developing countries, making them unaffordable for certain countries.
GlaxoSmithKline, Pfizer blamed for high vaccine prices  Livemint
GlaxoSmithKline plc Price Target Increased to GBX 1620 by Analysts at ...
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK) had its price target increased by Berenberg Bank from GBX 1,540 ($23.31) to GBX 1,620 ($24.52) in a research report sent to investors on Friday morning.
GlaxoSmithKline plc Receives "Underperform" Rating from Credit Suisse
Credit Suisse reiterated their underperform rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a research report released on Wednesday morning.
GlaxoSmithKline plc Downgraded by New Street Research (GSK)
New Street Research downgraded shares of GlaxoSmithKline plc (NYSE:GSK) to a reduce rating in a report issued on Thursday. Shares of GlaxoSmithKline plc (NYSE:GSK) traded up 0.07% during mid-day trading on Thursday, hitting $45.04. The stock had ...
New Street Research Rating Disclosure on GlaxoSmithKline plc (ADR)
In a research note released to the investors, New Street Research downgrades its rating on GlaxoSmithKline plc (ADR) (NYSE:GSK).
Credit Suisse Reaffirms Underperform Rating for GlaxoSmithKline plc (GSK)
Credit Suisse reaffirmed their underperform rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a research note issued to investors on Wednesday.
Sanford C. Bernstein Reiterates "Market Perform" Rating for ...  The Legacy
GlaxoSmithKline plc's Market Perform Rating Reiterated at Sanford C ...  sleekmoney
WM Morrison plc, BP plc, BHP Billiton plc, GlaxoSmithKline plc and Centrica ...
When a former dividend hero like Tesco scraps its final payout of the year, it's enough to give grown investors the blues. Especially when that comes on top of a previous 75% cut in its dividend payout.